Browse by author
Lookup NU author(s): Dr Mario Abinun, Dr Jonathan Lane, Dr Terence Flood, Emerita Professor Helen Foster
This is the final published version of an article that has been published in its final definitive form by Centers for Disease Control and Prevention, 2016.
For re-use rights please refer to the publisher's terms and conditions.
Severe infections are emerging as major risk factors for death among children with juvenile idiopathic arthritis (JIA). In particular, children with refractory JIA treated with long-term, multiple, and often combined immunosuppressive and antiinflammatory agents, including the new biological disease-modifying antirheumatic drugs (DMARDs), are at increased risk for severe infections and death. We investigated 4 persons with JIA who died during 1994-2013, three of overwhelming central venous catheter related bacterial sepsis caused by coagulase-negative Staphylococus or a-hemolytic Streptococcus infection and 1 of disseminated adenovirus and Epstein-Barr virus infection). All 4 had active JIA refractory to long-term therapy with multiple and combined conventional and biological DMARDs. Two died while receiving high-dose systemic corticosteroids, methotrexate, and after recent exposure to anti tumor necrosis factor-a biological DMARDs, and 2 during hematopoietic stem cell transplantation procedure. Reporting all cases of severe infections and especially deaths in these children is of paramount importance for accurate surveillance.
Author(s): Abinun M, Lane JP, Wood M, Friswell M, Flood TJ, Foster HE
Publication type: Article
Publication status: Published
Journal: Emerging Infectious Diseases
Year: 2016
Volume: 22
Issue: 10
Pages: 1720-1727
Print publication date: 01/10/2016
Acceptance date: 15/09/2016
Date deposited: 01/12/2016
ISSN (print): 1080-6040
ISSN (electronic): 1080-6059
Publisher: Centers for Disease Control and Prevention
URL: http://dx.doi.org/10.3201/eid2210.151245
DOI: 10.3201/eid2210.151245
Altmetrics provided by Altmetric
